Table 2.
Baseline clinical, biological and ART information of HIV-positive adults at initiation of HAART at Felege Hiwot Referral Hospital (January 2012 to December 2017) (n = 490).
| Variables | Category | n (%) |
|---|---|---|
| Weight at baseline | ≤60 | 187 (38.2) |
| >60 | 303 (61.8) | |
|
| ||
| BMI | Overweight | 60 (12.2) |
| Normal | 288 (58.8) | |
| Underweight | 142 (29.0) | |
|
| ||
| Functional status at baseline | Working | 224 (45.7) |
| Ambulatory | 202 (41.2) | |
| Bedridden | 64 (13.1) | |
|
| ||
| WHO staging at baseline | Stage 1 | 94 (19.2) |
| Stage 2 | 289 (59.0) | |
| Stage 3 | 88 (18.0) | |
| Stage 4 | 19 (3.9) | |
|
| ||
| Past prophylaxis | No | 235 (48.0) |
| Yes | 255 (52.0) | |
|
| ||
| CD4 count at baseline | <200 | 142 (29.0) |
| ≥200 | 348 (71.0) | |
|
| ||
| Baseline ART regimen | 1a = (30) d4t(30)/-3Tc-NVP | 6 (1.2) |
| 1a = (40) d4t(40)/-3Tc-NVP | 68 (13.9) | |
| 1b = (30) d4t(30)/-3Tc-EFV | 101 (20.6) | |
| 1b = (40) d4t(40)/-3Tc-EFV | 271 (55.3) | |
| 1c = AZT-3Tc-NVP | 27 (5.5) | |
| 1d = AZT-3Tc-EFV | 17 (3.5) | |
|
| ||
| Nutritional status | Severe acute malnutrition (BMI < 16 kg/m2) | 56 (11.4) |
| Moderate acute | 69 (14.1) | |
| Mild acute | 179 (36.5) | |
| Normal (BMI 18.5-24.9 kg/m2) | 186 (38) | |
BMI: body mass index; d4t: stavudine; 3Tc: lamivudine; NVP: nevirapine; EFV: efavirenz; AZT: zidovudine.